Navigation Links
AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
Date:5/14/2013

BOSTON, May 14, 2013 /PRNewswire/ -- On May 19-21 in Boston, clinical trial sponsors, CROs, sites and leaders from around the world will gather at the inaugural CenterWatch Forum on Optimizing Clinical Research Performance conference to discuss collaboration and innovation within a changing clinical trial research landscape.

Among the clinical trial leaders in attendance will be AG Mednet CEO Abraham Gutman who will moderate a special program about successful site leadership and disruptive technologies transforming investigator sites and challenging old assumptions among global networks.

Gutman, recently recognized by CenterWatch as one of 20 innovators changing the face of the clinical trial industry, is responsible for leading AG Mednet and its breakthrough technology that improves the quality of clinical trials by eliminating preventable and costly human errors.

For more information about AG Mednet or to schedule a conversation with Abraham Gutman about the role of disruptive technologies at clinical trial investigative sites around the world, please email agmednet@hbagency.com.

For more information about the Inaugural Forum on Optimizing Clinical Research Performance, please visit http://www.iibig.com/conferences/P1301/overview.html.

About AG Mednet

AG Mednet automates, expedites and improves outcomes in clinical trials by ensuring quality and compliance within critical medical imaging processes. Founded in 2005, AG Mednet is the leading quality compliance partner for image data submission and collection for pharmaceutical, biotechnology and medical device companies, imaging core labs and clinical research organizations managing clinical trials globally. More than 17,000 registered users across thousands of investigator sites in 60 countries use AG Mednet to participate in projects sponsored by each of the world's top 20 pharmaceutical, biotech and medical device companies.

Media Contact: 
Dawn Sullivan or Molly Delaney 
HB Agency 
781-893-0053 
agmednet@hbagency.com


'/>"/>
SOURCE AG Mednet
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. AG Mednet Announces Partnership with The Methodist DeBakey Heart & Vascular Center Echocardiography Core Lab
2. AG Mednet and Japans Biovisiq Bring Zero-Delay Clinical Trial Solutions to Asian Pharmaceutical Market
3. MedNet Solutions To Participate In Multiple Clinical Research Conferences In April 2013
4. AG Mednet Announces Cloud Storage Solution with On-Demand Access to Clinical Trial Data
5. MedNet Solutions To Sponsor And Participate In The 2012 SCDM Annual Conference
6. ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results
7. Prairie Education & Research Cooperative Joins MedNet Solutions iMedNet CRO Partner Program
8. MedNet Solutions to Unveil Innovative New iMedNet EDC Features at The 48th DIA Annual Meeting
9. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
10. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
11. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):